𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC

✍ Scribed by Athanasios G. Pallis; Vassilis Chandrinos; Georgia Pavlakou; Nikolaos Xenidis; Ioannis Varthalitis; Nikolaos Vardakis; Lambros Vamvakas; Emmanouel Kontopodis; Maria Rovithi; Vassilis Georgoulias


Publisher
Springer
Year
2010
Tongue
English
Weight
291 KB
Volume
67
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II trial of oral tegafur and ura
✍ Yukito Ichinose; Nobuko Takanashi; Tokujiro Yano; Hiroshi Asoh; Hideki Yokoyama; πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 391 KB πŸ‘ 2 views

## Background: The combination of uracil and tegafur in a 4:1 molar concentration (uft) has a greater antitumor activity than 5-fluorouracil (5-fu) and tegafur. because the combination of 5-fu and cisplatin has been proven to have a synergistic antitumor effect in many experimental and clinical stu

Phase I trial of docetaxel and vinorelbi
✍ Vincent A. Miller; Kenneth K. Ng; Lee M. Krug; Wendy Perez; Barbara Pizzo; Rober πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

## Background: With preclinical evidence of synergy, this dose-finding trial examining the combination of docetaxel and vinorelbine given with prophylactic filgrastim for the treatment of patients with nonsmall cell lung carcinoma was undertaken. ## Methods: Twenty-seven patients with advanced no

A phase I/II trial of neoadjuvant chemot
✍ Jean Viallet; Marc-AndrΓ© Brassard; Luis Souhami; Joseph Ayoub; Pierre Del Vecchi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 2 views

## BACKGROUND. Both locoregional and distant disease control remains poor in the treatment of Stage III nonsmall cell lung carcinoma (NSCLC). This trial was conducted to evaluate the tolerance and responses of patients with NSCLC given a neoadjuvant regimen of cisplatin and vinorelbine chemotherapy